What is LOPJLB’s current signal on KYTX?

LOPJLB’s latest quantitative signal on Kyverna Therapeutics, Inc. (KYTX) is BUY in a RECOVERY regime. Signals are updated daily.

What market regime is KYTX in?

Kyverna Therapeutics, Inc. (KYTX) is currently classified in the RECOVERY HMM market regime on LOPJLB.

What does Kyverna Therapeutics, Inc. (KYTX) do?

Kyverna Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing cell therapies for patients with autoimmune diseases. Its lead product candidate is KYV-101, an autologous CD19 CAR T-cell product candidate for the treatment of stiff person syndrome, myasthenia gravis, and lupus nephritis, as well as multiple sclerosis and systemic sclerosis. The company is also deve…

Where is Kyverna Therapeutics, Inc. based / listed?

Kyverna Therapeutics, Inc. is based in US, listed on NASDAQ.

Kyverna Therapeutics, Inc. (KYTX) Stock · BUY · RECOVERY

Key stats

Short interest · FINRA settlement 2026-07-31

Market cap: $501M
Avg volume: 1.1M
Beta: 1.94
P/E (TTM): -2.95

Short % float: 29.70%
Days to cover: 8.7
SI change: +4.2%

1W: -7.93%
1M: +11.20%
3M: -4.96%
YTD: -6.04%

vs SPY 1W: -6.74%
vs SPY 1M: +7.88%
vs SPY 3M: -7.35%
vs SPY YTD: -17.80%

Sector peers

Same-sector names ranked by LOPJLB quality proximity · Healthcare

Industry peers

FMP comparable companies · ranked by market cap

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Kyverna Therapeutics, Inc. (KYTX)

Key stats

Sector peers

Industry peers

Prediction markets

ANALYST & RATINGS

Company news